A severe decline in the use of estrogen therapy (ET) due to misunderstanding the findings of the Women’s Health Initiative (WHI) Estrogen Plus Progestin Trial has particularly affected hysterectomized women in their 50s, leading to excess mortality, according to a study published online in the American Journal of Public Health.
Obstetrics-Gynecology & Women's Health
Nonsteroidal anti-inflammatory drugs (NSAIDs) should be used with caution during pregnancy, as exposure may increase the risk of spontaneous abortion, reported a study published online September 6 in the Canadian Medical Association Journal.
A new report from the Institute of Medicine (IOM) recommends that 8 preventive health services for women be added to the services that health plans will cover at no cost to patients under the Patient Protection and Affordable Care Act of 2010.
The US Centers for Disease Control and Prevention has released revised recommendations for postpartum contraceptive use based on an assessment of new evidence, announced an article published in the July 8 issue of Morbidity and Mortality Weekly Report.
Medication use among pregnant women is widespread and increasing, according to a recent study from the Boston University School of Public Health in Boston.
The American Heart Association recently released its updated cardiovascular disease prevention guidelines for women. The guidelines emphasize practical medical advice that works in the ?real world? rather than on findings primarily observed in clinical research.
Postmenopausal women who were evaluated after taking conjugated equine estrogen had neither an increased nor decreased risk of coronary heart disease, and a decrease in breast cancer risk persisted, according to a post-intervention follow-up of the Women?s Health Initiative Estrogen-Alone Trial, published in the Journal of the American Medical Association.
Vaginal progesterone administered from the mid-trimester of pregnancy until term in women with a premature cervical shortening, as confirmed by transvaginal ultrasound, significantly reduced the rate of preterm birth before 33 weeks gestation, according to a phase 3 study published online in Ultrasound in Obstetrics & Gynecology.
This overview of some recently available OTC products marks the first time our Self Care page has focused on testing kits and accessories.
A DNA paternity test kit is available in New York retail pharmacies for the first time.